Special notice
Notice of Intent to Sole Source - Labcorp - Pertussis Diphtheria laboratory study
2024-86670
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Medical and Diagnostic Laboratories.
Response deadline
August 27, 2024 at 4:00 PM EDT
Closed 797 days ago. Posted August 12, 2024. Scheduled to archive September 11, 2024.
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
Description
As published on SAM.gov.
The purpose of this contract is to purchase 4680 deidentified nasopharyngeal specimens (selected weekly at random; 20 Bordetella pertussis positive, 20 positive for another Bordetella, 5 negative). The vendor shall provide 585 remnant nasopharyngeal specimens per quarter from diagnostic testing submitted from across the US public health jurisdiction to be used as representative inputs for pertussis pathogen genomic surveillance.
The vendor shall deidentify and relabel remnant specimens with a unique identifier prior to shipment. Samples can be stored frozen (-70C) and shipped on dry ice overnight to CDC accompanied by CDC’s Global File Accessioning Template (GFAT) form similar, which will include study ID, patient age (in years), gender, geographic location (zip code), and specimen collection date. CDC currently has an existing legal agreement with Labcorp for the material transfer of specimens for the project.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 12, 2024
Special notice
Due August 27, 2024 at 4:00 PM EDT. SAM.gov, notice 91595912dc8045328ada02dc8bc6a080
Points of contact
- Marcus Lindseyyzg2@cdc.gov7704885242